Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.022 | 0.7 |